In NSCLC cell lines, cisplatin exposure increased Rad51 protein induction, and reduction in Rad51 by siRNA significantly increased cisplatin‐mediated cell kill by cisplatin 15, 18, 19, 20. The gene discussed is RAD51; the disease is non-small cell lung carcinoma.